Timothy Sullivan
Directeur Financier/CFO chez APELLIS PHARMACEUTICALS, INC.
Fortune : 7 M $ au 30/04/2024
Profil
Timothy Eugene Sullivan est directeur financier et trésorier chez Apellis Pharmaceuticals, Inc. Dans le passé, M. Sullivan a occupé les postes de vice-président exécutif et responsable du développement de l'entreprise chez Rafael Pharmaceuticals, Inc, de directeur général et responsable des services bancaires d'investissement dans le domaine des sciences de la vie chez Citizens Bank, NA (Providence, Rhode Island) et d'associé chez Aju IB Investment Co, Ltd. (capital-investissement). M. Sullivan a obtenu un MBA à la Columbia Business School et un diplôme de premier cycle à l'Université de Harvard.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 18/04/2024 | 149 570 ( 0,12% ) | 7 M $ | 30/04/2024 |
Postes actifs de Timothy Sullivan
| Sociétés | Poste | Début |
|---|---|---|
| APELLIS PHARMACEUTICALS, INC. | Directeur Financier/CFO | 01/10/2017 |
Anciens postes connus de Timothy Sullivan
| Sociétés | Poste | Fin |
|---|---|---|
Aju IB Investment Co., Ltd. (Private Equity)
 Aju IB Investment Co., Ltd. (Private Equity) Investment ManagersFinance Aju IB Investment Co., Ltd. (Aju IB) is the venture capital subsidiary of AJU Capital Co., Ltd founded in 1974 by Korea Technology Development Corp. The firm is headquartered in Seoul, Korea. | Corporate Officer/Principal | 01/10/2017 |
Molecular Templates, Inc. /Old/
 Molecular Templates, Inc. /Old/ BiotechnologyHealth Technology Molecular Templates, Inc. operates as a holding company that engages in the discovery and development of immunotoxins for the treatment of cancer and other serious diseases. These are capable of targeting validated therapeutic cell surface receptors but also non-traditional targets that cannot be therapeutically targeted by antibodies or small molecules. Its product pipeline consists of lead candidates for non-Hodgkin's lymphoma, multiple myeloma, and breast cancer. The company was founded by Jean Gariépy and Leigh Revers in 2009 and is headquartered in Georgetown, TX. | Directeur/Membre du Conseil | 01/07/2017 |
| G1 THERAPEUTICS, INC. | Directeur/Membre du Conseil | 22/05/2017 |
Citizens Bank, NA (Providence, Rhode Island)
 Citizens Bank, NA (Providence, Rhode Island) Major BanksFinance Citizens Bank NA provides commercial banking services. It offers credit cards, borrowing services, student lending solutions, retirement plans, and wealth management and investment services. The company is headquartered in Providence, RI. | Directeur Général | 01/01/2014 |
Cornerstone Pharmaceuticals, Inc.
 Cornerstone Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Rafael Pharmaceuticals, Inc. develops anti-cancer drug delivery technology. It produces highly selective and effective anti-cancer agents with minimal toxic effects on normal cells and tissues by attacking regulatory processes that are unique to cancer and not found in healthy cells. The firm would ensure a significant improvement in the safety profile of cancer treatment. The firm provides CPI-613, Altered Energy Metabolism Directed (AEMD) platform, targets enzymes that are involved in cancer cell energy metabolism and are located in the mitochondria of cancer cells. The company was founded by Robert G. L. Shorr and is headquartered in Cranbury, NJ. | Corporate Officer/Principal | 01/12/2011 |
Formation de Timothy Sullivan
| Columbia Business School | Masters Business Admin |
| Harvard University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| APELLIS PHARMACEUTICALS, INC. | Health Technology |
| G1 THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Cornerstone Pharmaceuticals, Inc.
Cornerstone Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Rafael Pharmaceuticals, Inc. develops anti-cancer drug delivery technology. It produces highly selective and effective anti-cancer agents with minimal toxic effects on normal cells and tissues by attacking regulatory processes that are unique to cancer and not found in healthy cells. The firm would ensure a significant improvement in the safety profile of cancer treatment. The firm provides CPI-613, Altered Energy Metabolism Directed (AEMD) platform, targets enzymes that are involved in cancer cell energy metabolism and are located in the mitochondria of cancer cells. The company was founded by Robert G. L. Shorr and is headquartered in Cranbury, NJ. | Commercial Services |
Aju IB Investment Co., Ltd. (Private Equity)
Aju IB Investment Co., Ltd. (Private Equity) Investment ManagersFinance Aju IB Investment Co., Ltd. (Aju IB) is the venture capital subsidiary of AJU Capital Co., Ltd founded in 1974 by Korea Technology Development Corp. The firm is headquartered in Seoul, Korea. | Finance |
Molecular Templates, Inc. /Old/
Molecular Templates, Inc. /Old/ BiotechnologyHealth Technology Molecular Templates, Inc. operates as a holding company that engages in the discovery and development of immunotoxins for the treatment of cancer and other serious diseases. These are capable of targeting validated therapeutic cell surface receptors but also non-traditional targets that cannot be therapeutically targeted by antibodies or small molecules. Its product pipeline consists of lead candidates for non-Hodgkin's lymphoma, multiple myeloma, and breast cancer. The company was founded by Jean Gariépy and Leigh Revers in 2009 and is headquartered in Georgetown, TX. | Health Technology |
Citizens Bank, NA (Providence, Rhode Island)
Citizens Bank, NA (Providence, Rhode Island) Major BanksFinance Citizens Bank NA provides commercial banking services. It offers credit cards, borrowing services, student lending solutions, retirement plans, and wealth management and investment services. The company is headquartered in Providence, RI. | Finance |
